SCHOTT Pharma AG & Co. KGaA (ETR: 1SXP)

Market Cap	3.78B
Revenue (ttm)	957.09M
Net Income (ttm)	149.69M
Shares Out	150.61M
EPS (ttm)	0.99
PE Ratio	25.33
Forward PE	23.80
Dividend	0.16 (0.66%)
Ex-Dividend Date	Feb 5, 2025

Volume	29,183
Open	24.42
Previous Close	24.34
Day's Range	24.26 - 25.36
52-Week Range	22.64 - 43.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 1SXP

Financial Performance

In 2024, SCHOTT Pharma AG & Co. KGaA's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.